| Health / Medical Topics |
MAGE-3 Peptide Vaccine
A cancer vaccine consisting of a peptide derived from MAGE-3 and the pan-DR epitope (PADRE), an immunostimulant. Vaccination with CY-2010 may elicit a cytotoxic T lymphocyte (CTL) immune response against tumor cells expressing MAGE-3. MAGE-is an antigen found on many tumor cell types, including melanoma and lung, prostate, colon, thyroid, and breast cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A peptide derived from MAGE-3, a tumor-associated protein expressed by a variety of cancer cell types, including melanoma, breast, colon, lung, and…
A protein found in many types of tumors but not in most normal tissues. Vaccines using pieces of the MAGE-3 protein are…
A synthetic peptide consisting of the amino acids 170 through 178 of the MAGE-12 melanoma antigen. MAGE-12 170-178 has been identified…
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an…
A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that…
A cancer vaccine consisting of a recombinant vaccinia virus encoding the tumor-associated gene MAGE-1 that is contaminated with bovine viral diarrhea virus…
